Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paolo Pozzilli

Showing results (41-50 of 264) with videos related to

Pageof 27
Sort By:
Diabetes/Metabolism Research and Reviews|November 20, 2004
Glucose control in diabetesCristina Valeri, Paolo Pozzilli, David Leslie
Diabetes/Metabolism Research and Reviews|January 3, 2013
Latent autoimmune diabetes in the adults (LADA) in Asia: from pathogenesis and epidemiology to therapyChiara Guglielmi, Andrea Palermo, Paolo Pozzilli
Diabetes/Metabolism Research and Reviews|October 21, 2015
Frailty and geography: should these two factors be added to the ABCDE contemporary guide to diabetes therapy?Ernesto Maddaloni, Luca D'Onofrio, Paolo Pozzilli
Journal of Diabetes and Its Complications|July 20, 2025
What type 1 diabetes endotype is most suitable for anti-CD3 antibodies prevention trials?Maria Aurora Roma Wilson, Paolo Pozzilli
Journal of Diabetes Investigation|May 21, 2014
One size does not fit all glycemic targets for type 2 diabetesPaolo Pozzilli, Rocky Strollo, Enzo Bonora
Diabetes Care|October 31, 2009
Beta-cell protection and therapy for latent autoimmune diabetes in adultsSimona Cernea, Raffaella Buzzetti, Paolo Pozzilli
Nature Reviews. Endocrinology|February 18, 2015
Combination immunotherapies for type 1 diabetes mellitusPaolo Pozzilli, Ernesto Maddaloni, Raffaella Buzzetti
Diabetes/Metabolism Research and Reviews|May 20, 2023
Diabetes, COVID-19, and questions unsolvedFelecia D'Souza, Raffaella Buzzetti, Paolo Pozzilli
Diabetes, Obesity & Metabolism|March 12, 2020
Impact of obesity on the increasing incidence of type 1 diabetesRaffaella Buzzetti, Simona Zampetti, Paolo Pozzilli
Expert Opinion on Biological Therapy|April 21, 2012
Buccal spray insulin (Oralgen) for type 2 diabetes: what evidence?Andrea Palermo, Ernesto Maddaloni, Paolo Pozzilli
Pageof 27

Showing results (41-50 of 264) with videos related to

Sort By:
Pageof 27
Diabetes/Metabolism Research and Reviews|November 20, 2004
Glucose control in diabetesCristina Valeri, Paolo Pozzilli, David Leslie
Diabetes/Metabolism Research and Reviews|January 3, 2013
Latent autoimmune diabetes in the adults (LADA) in Asia: from pathogenesis and epidemiology to therapyChiara Guglielmi, Andrea Palermo, Paolo Pozzilli
Diabetes/Metabolism Research and Reviews|October 21, 2015
Frailty and geography: should these two factors be added to the ABCDE contemporary guide to diabetes therapy?Ernesto Maddaloni, Luca D'Onofrio, Paolo Pozzilli
Journal of Diabetes and Its Complications|July 20, 2025
What type 1 diabetes endotype is most suitable for anti-CD3 antibodies prevention trials?Maria Aurora Roma Wilson, Paolo Pozzilli
Journal of Diabetes Investigation|May 21, 2014
One size does not fit all glycemic targets for type 2 diabetesPaolo Pozzilli, Rocky Strollo, Enzo Bonora
Diabetes Care|October 31, 2009
Beta-cell protection and therapy for latent autoimmune diabetes in adultsSimona Cernea, Raffaella Buzzetti, Paolo Pozzilli
Nature Reviews. Endocrinology|February 18, 2015
Combination immunotherapies for type 1 diabetes mellitusPaolo Pozzilli, Ernesto Maddaloni, Raffaella Buzzetti
Diabetes/Metabolism Research and Reviews|May 20, 2023
Diabetes, COVID-19, and questions unsolvedFelecia D'Souza, Raffaella Buzzetti, Paolo Pozzilli
Diabetes, Obesity & Metabolism|March 12, 2020
Impact of obesity on the increasing incidence of type 1 diabetesRaffaella Buzzetti, Simona Zampetti, Paolo Pozzilli
Expert Opinion on Biological Therapy|April 21, 2012
Buccal spray insulin (Oralgen) for type 2 diabetes: what evidence?Andrea Palermo, Ernesto Maddaloni, Paolo Pozzilli
Pageof 27